Related Experiment Video
Updated: Apr 4, 2026

14:21
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
19.0K
Resting-state functional connectivity and nicotine addiction: prospects for biomarker development
John R Fedota1, Elliot A Stein1
1Neuroimaging Research Branch, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland.
Annals of the New York Academy of Sciences
|September 9, 2015
Summary
Resting-state functional connectivity reveals how nicotine addiction affects brain networks. Chronic nicotine reduces network efficiency, while acute nicotine alters limbic circuits, offering insights into addiction biomarkers.
Area of Science:
- Neuroscience
- Addiction Research
- Neuroimaging
Background:
- Addiction is conceptualized as a disease affecting brain network communication.
- Examining network interactions offers a holistic view of addiction-related dysfunction.
- Resting-state functional connectivity (rsFC) is a key methodological approach.
Purpose of the Study:
- To characterize addiction-related neural dysfunction using rsFC.
- To investigate the differentiated effects of acute and chronic nicotine exposure on brain networks.
- To explore the potential for neuroimaging-based addiction biomarkers.
Main Methods:
- Quantification of correlations in low-frequency BOLD-fMRI signal fluctuations between brain regions during rest.
- Analysis of large-scale resting networks (salience, default, executive control).
- Examination of connectivity dynamics during nicotine withdrawal and satiety.
Main Results:
- Chronic nicotine exposure reduces overall brain network communication efficiency.
- Acute nicotine exposure increases connectivity within specific limbic circuits.
- Modulations in rsFC are observed at various stages of nicotine addiction.
Conclusions:
- Resting-state functional connectivity provides a framework to understand the neurobiological mechanisms of nicotine addiction.
- Simultaneous quantification of chronic and acute nicotine effects offers a platform for developing neuroimaging-based biomarkers.
- Future research should focus on identified network interactions for biomarker development.
More Related Videos
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
1.6K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.6K
Drugs Acting on Autonomic Ganglia: Stimulants
2.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.3K

